Humulin R Dosage/Direction for Use

Posology: The dosage should be determined by the physician, according to the requirement of the patient.
Pediatric population: No data are available.
Method of administration: Insulin Human (rDNA) (Humulin R) should be given by subcutaneous injection. It may also be administered intravenously.
Subcutaneous administration should be in the upper arms, thighs, buttocks or abdomen. Use of injection sites should be rotated so that the same site is not used more than approximately once a month in order to reduce the risk of lipodystrophy and cutaneous amyloidosis (see Precautions and Adverse Reactions).
Care should be taken when injecting any Insulin Human (Humulin) preparation to ensure that a blood vessel has not been entered. After any insulin injection, the injection site should not be massaged. Patients must be educated to use proper injection techniques.
Insulin Human (rDNA) (Humulin N) may be administered in combination with Insulin Human (rDNA) (Humulin R) (see Instructions for use and handling: Mixing of Insulins under Cautions for Usage).